Related Experiment Video
Updated: Jun 7, 2025

Point-of-Care Lung Ultrasound in Adults: Image Acquisition
Published on: March 3, 2023
Quality assurance in lung cancer screening
Adnan G Taib1, Iain T H Au-Yong2, Arjun Nair3
1Translational Medical Sciences, School of Medicine, University of Nottingham, Clinical Sciences Building, Nottingham City Hospital Campus, Nottingham NG5 1PB, United Kingdom.
External quality assurance (EQA) rapidly tests clinical expertise for cancer screening programs. This study details the first EQA for lung cancer screening, leveraging experience from established breast cancer screening EQA.
Area of Science:
- Medical Imaging
- Public Health
- Oncology
Background:
- Screening program effectiveness hinges on accurate tests, especially those relying on clinical expertise.
- Auditing reader performance in image-based cancer screening is challenging due to data accumulation delays.
- Delayed identification of underperformance can necessitate participant recalls and erode program confidence.
Purpose of the Study:
- To develop the first External Quality Assurance (EQA) process for lung cancer screening.
- To adapt and apply lessons learned from over 30 years of breast cancer screening EQA.
- To establish a rapid method for assessing and assuring clinical expertise in lung cancer screening.
Main Methods:
- Utilizing test datasets with confirmed clinical outcomes for rapid expertise assessment.
- Leveraging established methodologies from the UK's long-standing breast cancer screening EQA program.
- Describing the developmental process of a novel EQA for lung cancer screening.
Main Results:
- Established the foundational framework for the first lung cancer screening EQA process.
- Demonstrated the feasibility of rapidly assessing reader expertise using EQA methodologies.
- Identified areas for future development and refinement of the lung cancer screening EQA.
Conclusions:
- External Quality Assurance (EQA) provides a vital mechanism for ensuring reader expertise in cancer screening.
- The developed EQA process for lung cancer screening is adaptable and builds upon successful breast cancer screening models.
- Ongoing development of EQA is crucial for maintaining high standards and public confidence in screening programs.
More Related Videos
07:59Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
07:43Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients
Published on: September 25, 2018
Related Concept Videos
Radiological Investigation II: MRI and Ventilation Perfusion Scan
Magnetic Resonance Imaging (MRI) and Ventilation Perfusion Scans are two radiological investigations that offer detailed diagnostic images of the body, particularly lung structures.
MRI
MRI uses magnetic fields and radiofrequency signals to distinguish between normal and abnormal tissues. This technology provides a more detailed diagnostic image than CT scans, enabling it to characterize pulmonary nodules, stage bronchogenic carcinoma, and evaluate inflammatory activity in...
Radiological Investigation III: Pulmonary Angiogram and PET Scan
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Quality Assurance